Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Operating Margin (2021 - 2023)

Senti Biosciences has reported Operating Margin over the past 3 years, most recently at 12981.07% for Q3 2023.

  • Quarterly results put Operating Margin at 12981.07% for Q3 2023, down 1200824.0% from a year ago — trailing twelve months through Jun 2024 was 27287.28% (down 2554844.0% YoY), and the annual figure for FY2025 was 312631.82%, changed.
  • Operating Margin for Q3 2023 was 12981.07% at Senti Biosciences, down from 2210.77% in the prior quarter.
  • Over the last five years, Operating Margin for SNTI hit a ceiling of 972.82% in Q3 2022 and a floor of 28464.41% in Q4 2022.
  • Median Operating Margin over the past 3 years was 1215.22% (2021), compared with a mean of 5240.94%.
  • Peak annual rise in Operating Margin hit 26076bps in 2022, while the deepest fall reached -2726754bps in 2022.
  • Senti Biosciences' Operating Margin stood at 1196.86% in 2021, then tumbled by -2278bps to 28464.41% in 2022, then skyrocketed by 54bps to 12981.07% in 2023.
  • The last three reported values for Operating Margin were 12981.07% (Q3 2023), 2210.77% (Q2 2023), and 1163.61% (Q1 2023) per Business Quant data.